Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jinzhen Oral Liquid for COVID-19 in Children
NCT05507489Unknown
- Sponsor
- The Affiliated Hospital of Qingdao University
- Start
- Mar 2022
- Primary completion
- Sep 2022
- Modality
- Botanical Extract
- Countries
- 1
01
Overview
Randomised, open-label trial of Jinzhen Oral Solution in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by The Affiliated Hospital of Qingdao University. Primary endpoint: First negative time of COVID-19 up to 6 months. Status: unknown.
02
Drugs
Jinzhen Oral Solution
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05507489.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05507489.